An experimental COVID-19 treatment pill, called molnupiravir and being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP, is seen in this undated handout photo released by Merck & Co Inc and obtained by Reuters May 17, 2021.An experimental COVID-19 treatment pill, called molnupiravir and being developed by Merck & Co Inc and Ridgeback Biotherapeutics LP, is seen in this undated handout photo released by Merck & Co Inc and obtained by Reuters May 17, 2021.
The drug, called VV116, is a derivative of Gilead SciencesInc’s COVID-19 drug remdesivir and was approved for use in moderate to severe cases in Uzbekistan last year. Participants were given either the five-day course oral drug along with standard treatment or standard treatment only, researchers said in a paper Emerging Microbes & Infections.
Limitations of the study include the small trial size and a higher portion of participants in the control group reporting symptoms, which could result in potential bias that researchers had to adjust with the statistical model, the paper said.
A nother drug quickly made
I am super excited right now, I can now pay my bills and take good care of my family.. Thank you for bringing happiness to my home with just $5000 i got $50,000 in 7days Williamchurch07
Lmao
yup/// pfizer's pill is also reaylly successfull.. at killing people.. orally this time...